Rui Kamada

1.5k total citations
69 papers, 1.1k citations indexed

About

Rui Kamada is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Rui Kamada has authored 69 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 20 papers in Cardiology and Cardiovascular Medicine and 19 papers in Oncology. Recurrent topics in Rui Kamada's work include Cancer-related Molecular Pathways (18 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Cardiac Arrhythmias and Treatments (11 papers). Rui Kamada is often cited by papers focused on Cancer-related Molecular Pathways (18 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Cardiac Arrhythmias and Treatments (11 papers). Rui Kamada collaborates with scholars based in Japan, United States and Canada. Rui Kamada's co-authors include Kazuyasu Sakaguchi, H. Sugimoto, Takuya Kato, Takao Nomura, Kong Fai Tai, Takeshi Yagioka, Toshiaki Imagawa, Shunsuke Adachi, Yoshiro Chuman and James G. Omichinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Rui Kamada

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Kamada Japan 17 471 320 320 208 124 69 1.1k
Ray Mernaugh United States 20 756 1.6× 88 0.3× 104 0.3× 378 1.8× 158 1.3× 36 1.6k
Qingrun Li China 18 682 1.4× 104 0.3× 133 0.4× 77 0.4× 47 0.4× 75 1.2k
Chih-Cheng Yang Taiwan 16 458 1.0× 335 1.0× 196 0.6× 89 0.4× 159 1.3× 47 1.3k
Junye Liu China 18 520 1.1× 113 0.4× 205 0.6× 112 0.5× 41 0.3× 63 1.1k
Yu Xi China 15 371 0.8× 222 0.7× 89 0.3× 212 1.0× 122 1.0× 27 1.0k
Haoran Xu China 21 612 1.3× 104 0.3× 198 0.6× 137 0.7× 130 1.0× 78 1.3k
Sharmistha Das India 17 495 1.1× 149 0.5× 178 0.6× 96 0.5× 63 0.5× 48 1.0k
Elena A. Dubikovskaya Switzerland 15 602 1.3× 73 0.2× 128 0.4× 79 0.4× 32 0.3× 23 1.3k
Miwa Sato Japan 12 355 0.8× 79 0.2× 107 0.3× 88 0.4× 73 0.6× 24 703

Countries citing papers authored by Rui Kamada

Since Specialization
Citations

This map shows the geographic impact of Rui Kamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Kamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Kamada more than expected).

Fields of papers citing papers by Rui Kamada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Kamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Kamada. The network helps show where Rui Kamada may publish in the future.

Co-authorship network of co-authors of Rui Kamada

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Kamada. A scholar is included among the top collaborators of Rui Kamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Kamada. Rui Kamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watanabe, Masaya, Takuya Koizumi, Yuta Kobayashi, et al.. (2023). Fragmented QRS on 12-lead electrocardiogram predicts long-term prognosis in patients with cardiac sarcoidosis. Heart and Vessels. 38(6). 803–816. 4 indexed citations
2.
Watanabe, Masaya, Takuya Koizumi, Motoki Nakao, et al.. (2023). Empagliflozin attenuates arrhythmogenesis in diabetic cardiomyopathy by normalizing intracellular Ca2+ handling in ventricular cardiomyocytes. American Journal of Physiology-Heart and Circulatory Physiology. 324(3). H341–H354. 24 indexed citations
3.
Kamada, Rui, et al.. (2023). Highly Similar Tetramerization Domains from the p53 Protein of Different Mammalian Species Possess Varying Biophysical, Functional and Structural Properties. International Journal of Molecular Sciences. 24(23). 16620–16620. 1 indexed citations
4.
Janairo, Jose Isagani B., et al.. (2023). Biomineralization through a Symmetry-Controlled Oligomeric Peptide. Biomimetics. 8(8). 606–606. 1 indexed citations
5.
Koizumi, Takuya, Masaya Watanabe, Takashi Yokota, et al.. (2023). Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats. Frontiers in Cardiovascular Medicine. 10. 1005408–1005408. 37 indexed citations
6.
7.
Watanabe, Masaya, et al.. (2022). Pharmacological nNOS inhibition modified small-conductance Ca2+-activated K+ channel without altering Ca2+ dynamics. American Journal of Physiology-Heart and Circulatory Physiology. 323(5). H869–H878.
8.
Janairo, Jose Isagani B., et al.. (2022). Ribosomal protein uL30 undergoes phase separation with nucleophosmin and regulates nucleolar formation in the absence of RNA. Biochemical and Biophysical Research Communications. 642. 35–40. 2 indexed citations
9.
Watanabe, Masaya, et al.. (2022). Intrinsic anti-tachycardia pacing terminated ventricular tachycardia resistant to traditional anti-tachycardia pacing. Indian Pacing and Electrophysiology Journal. 22(2). 99–102. 8 indexed citations
10.
Watanabe, Masaya, et al.. (2021). Hybrid epicardial ventricular tachycardia ablation with lateral thoracotomy in a patient with a history of left ventricular reconstruction surgery. Journal of Cardiology Cases. 25(1). 37–41. 2 indexed citations
11.
Ito, Shogo, Yutaka Matsuyama, James G. Omichinski, et al.. (2021). Role of active site arginine residues in substrate recognition by PPM1A. Biochemical and Biophysical Research Communications. 581. 1–5. 1 indexed citations
12.
Kamada, Rui, et al.. (2020). 選択的PIASファミリー蛋白質に存在するC末端SUMO相互作用モチーフの特性化【JST・京大機械翻訳】. Structure. 28(5). 573–585. 3 indexed citations
13.
Kamada, Rui, Takuya Koizumi, Atsushi Tada, et al.. (2020). Refractory Ventricular Tachycardia in a Patient With a Left Ventricular Assist Device Successfully Treated With Stellate Ganglion Phototherapy. Canadian Journal of Cardiology. 36(12). 1977.e1–1977.e3. 4 indexed citations
14.
Nomura, Takao, et al.. (2019). The tetramerization domain of the tree shrew p53 protein displays unique thermostability despite sharing high sequence identity with the human p53 protein. Biochemical and Biophysical Research Communications. 521(3). 681–686. 3 indexed citations
15.
Takahashi, Masayuki, Hisashi Yokoshiki, Hirofumi Mitsuyama, et al.. (2018). Evaluation of the pulmonary artery potential using a 20-polar circumferential catheter and three-dimensional integrated intracardiac echocardiography. Heart and Vessels. 34(1). 74–83.
16.
17.
Chuman, Yoshiro, et al.. (2015). Novel inhibitors targeting PPM1D phosphatase potently suppress cancer cell proliferation. Bioorganic & Medicinal Chemistry. 23(19). 6246–6249. 26 indexed citations
18.
Matsuo, Kazuya, Rui Kamada, Keigo Mizusawa, et al.. (2013). Specific Detection and Imaging of Enzyme Activity by Signal‐Amplifiable Self‐Assembling 19F MRI Probes. Chemistry - A European Journal. 19(38). 12875–12883. 33 indexed citations
19.
Muscolini, Michela, Silvana Caristi, Takao Nomura, et al.. (2009). Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain. Cell Cycle. 8(20). 3396–3405. 15 indexed citations
20.
Kamada, Rui, et al.. (2009). Effects of Tumor-Associated Mutations in the p53 Tetramerization Domain on Oligomerization State and Transcriptional Activity. Advances in experimental medicine and biology. 611. 567–568. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026